Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer. The study has been published in the journal PLoS One The classification of these three variants will improve genetic counseling of patients and families who have these mutations and will serve to personalize the treatment...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment